Dual Use of Bladder Anticholinergics and Cholinesterase Inhibitors: Long-Term Functional and Cognitive Outcomes

Authors

Kaycee M. Sink, School of Medicine, Wake Forest University, Winston-Salem, NC
Joseph Thomas III, Center for Health Outcomes Research and Policy (CHORP), Regenstrief Center for Healthcare Engineering (RCHE), Purdue University, West Lafayette, IN
Huiping Xu, Department of Statistics, Purdue University, West Lafayette, IN
Bruce Craig, Department of Statistics, Purdue University, West Lafayette, IN
Steven Kritchevsky, School of Medicine, Wake Forest University, Winston-Salem, NC
Laura P. Sands, Center for Health Outcomes Research and Policy (CHORP), Regenstrief Center for Healthcare Engineering (RCHE), Purdue University, West Lafayette, IN

Abstract

To determine the cognitive and functional consequences of dual use of cholinesterase inhibitors (ChIs) and the bladder anticholinergics oxybutynin or tolterodine.

Keywords

dementia, incontinence, pharmacotherapy, anticholinergics, cholinesterase inhibitors

Date of this Version

January 2008